SCHEMBL19976157

SCHEMBL19976157

CO[C@@H]1OC(CO)[C@@H](O[C@@H]2OC(CO)[C@H](O)C(NC(=O)c3ccc(C(C)=O)cc3)C2O)C(O)C1NC(C)=O

nearest known ligand 0.79

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 11/20 0.79
▸ LGALS7; LGALS7B P47929 4/20 0.70
▸ LGALS1 P09382 2/20 0.70
▸ LGALS9 O00182 4/20 0.56
▸ CA1 P00915 5/20 0.56
▸ CA2 P00918 5/20 0.56
▸ CA9 Q16790 5/20 0.56
▸ LGALS8 O00214 1/20 0.51
▸ LGALS4 P56470 1/20 0.51
▸ CHIA Q9BZP6 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17681085 1.00 LGALS3 (0.79) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL19976179 0.94 LGALS3 (0.79) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL17681096 0.94 LGALS3 (0.79) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL5356735 0.92 LGALS3 (0.82) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL5356738 0.92 LGALS3 (0.82) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL19976176 0.92 LGALS3 (0.75) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL17681095 0.92 LGALS3 (0.75) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL17681079 0.88 LGALS3 (1.00) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL19976177 0.88 LGALS3 (1.00) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1
SCHEMBL5354309 0.85 LGALS3 (0.84) LGALS3LGALS7; LGALS7BLGALS1LGALS9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9921230-B2 Methods for diagnosis and treatment of concussion or brain injury RHODE ISLAND HOSPITAL (US) 2018-03-20 — — US disclosed
Send feedback